9:22 AM
Leo Group India
| ||
| Pharmaceutical sector's concern Pakistan Daily Times KARACHI: The pharmaceutical industry has termed the duty cut on raw material as minimal measure for rescuing medicines prices from hike, saying the relief is far less than the increasing cost of production by the manufacturers. See all stories on this topic » | ||
| Pharmaceutical Industry Relies on Medical Science Liaisons to Generate Value ... Business Review India (press release) CHAPEL HILL, NC, June 1, 2012 /PRNewswire/ -- Medical Science Liaisons build relationships between the pharmaceutical industry and key stakeholders in the marketplace. In recent years, the role of Medical Science Liaisons (MSLs) has expanded across a ... See all stories on this topic » | ||
| Anacor Pharmaceuticals Appoints Paul L. Berns to Its Board of Directors MarketWatch (press release) PALO ALTO, Calif., Jun 01, 2012 (BUSINESS WIRE) -- Anacor Pharmaceuticals (NASDAQ:ANAC) announced today the appointment of Paul L. Berns to its Board of Directors. Since 2006, Mr. Berns has served as the President, Chief Executive Officer, ... See all stories on this topic » | ||
| Important Factors in Selecting a Localization Provider for the Pharmaceutical ... San Francisco Chronicle (press release) www.merrillbrink.com: The growing economic power, population and consumption of countries like China, India and Brazil mean that there is added pressure on pharmaceutical and medical device firms to ensure they invest in quality localization. See all stories on this topic » | ||
| Customs duty reduced on 88 pharmaceutical raw materials The News International Finance Minister Abdul Hafeez Sheikh, while presenting the budgetary speech on Friday, said that for availability of medicines at reasonable prices, the customs duty on 88 raw materials of pharmaceutical industry was being reduced from 10 percent to 5 ... See all stories on this topic » | ||
| RSI Alert For Top-Ranked Teva Pharmaceutical Industries Forbes Teva Pharmaceutical Industries Ltd (NYSE: TEVA) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors. See all stories on this topic » | ||
| Jubilee Special: 60 Years of Pharmaceuticals DailyFinance It's a similar story at AstraZeneca (NYS: AZN) , the UK's second-largest pharmaceutical company. Although AstraZeneca doesn't have the consumer brands of GSK, its focus on treatments to address cardiovascular, oncology, neuroscience, gastrointestinal, ... See all stories on this topic » | ||
| Siegfried buys California based Alliance Medical Products pharmabiz.com The acquisition of privately-held Alliance Medical Products (AMP) by the Swiss pharmaceutical supplier represents an important step toward additional profitable growth. The purchase price consists of a cash payment in the amount of US$ 58 million and ... See all stories on this topic » | ||
| Pharmaceutical manufactures not satisfied Business Recorder (blog) Despite reduction of customs duty by 5 percent on pharmaceutical raw materials in budget 2012-2013, the pharmaceutical manufacturers are not satisfied by the measure, as they say the industry is already enjoying 5 percent customs duty on import of ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment